YOLFTbeta
P3 Health Partners Inc

P3 Health Partners Inc

PIII · NASDAQ · Healthcare / Medical Care Facilities

2.70USD-0.05 (-1.82%)

Price History

Full chart

Market Stats

Previous Close2.75
Open2.77
Day Range2.51 – 2.81
52-Week Range1.52 – 16.89
Volume29.46K
Market Cap1.44B
P/E (TTM)0.00
Forward P/E0.00
EPS-33.01
Dividend Yield0.00%
Beta1.62
50-Day Avg9.69
200-Day Avg6.42

About

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Aric Coffman M.D.
  • Employees320
  • Headquarters2370 Corporate Circle, Henderson, NV, United States, 89074, USA
  • Websitehttps://p3hp.org

Leadership

  • Dr. Aric Coffman M.D.CEO, President & Director · b. 1974
  • Dr. Amir Bacchus M.B.A., M.D.Co-Founder, Chief Medical Officer & Director · b. 1965
  • Mr. Leif PedersenChief Financial Officer · b. 1976
  • Mr. William BettermannExecutive VP & COO
  • Mr. Devery GoodeySenior Vice President of Technology
  • Ms. Sarah Bussmann B.S.N., CRNI, M.H.A., R.N.Chief Administrative Officer
  • Mr. William HooverInvestor Relations Officer
  • Mr. Todd M. SmithChief Legal Officer, Chief Compliance Officer & Corporate Secretary
  • Ms. Kassi Belz APRExecutive Vice President of Marketing & Communications
  • Ms. Shelly MartinRegional President of Nevada & Arizona

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue87.70M145.48M491.06M-1.05B1.27B1.50B1.46B
Growth (%)-+65.89%+237.54%--+20.67%+18.48%-2.76%
Cost of Revenue-141.03M485.30M-668.07M1.23B1.56B1.60B
Gross Profit87.70M145.48M491.06M-1.05B1.27B1.50B-144.32M
Gross Margin100.00%100.00%100.00%-100.00%100.00%100.00%-9.89%
Operating Expense137.41M185.02M519.65M-2.61B1.43B1.81B125.98M
Operating Income-49.71M-39.54M-28.59M--1.56B-167.93M-312.60M-270.30M
Operating Margin-56.69%-27.18%-5.82%--148.73%-13.26%-20.83%-18.53%
EBITDA-49.37M-39.04M-28.08M--1.46B-81.07M-197.76M-181.86M
EBITDA Margin-56.30%-26.83%-5.72%--139.21%-6.40%-13.18%-12.46%
Net Income-43.80M-41.97M-31.41M--270.13M-57.77M-135.85M-147.95M
Net Income Margin-49.95%-28.85%-6.40%--25.74%-4.56%-9.05%-10.14%
Interest Expense44.23K2.53M2.53M-11.40M15.98M22.17M55.03M
Interest Expense % of Total Revenue0.05%1.74%0.52%-1.09%1.26%1.48%3.77%

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-65.61M106.44M2.36B876.74M860.97M783.42M656.64M
Total Liabilities-121.54M236.65M299.94M354.08M427.31M633.89M796.88M
Total Equity--42.05M-130.22M2.06B5.85M142.13M75.94M-155.23M
Cash-32.59M36.26M140.48M18.46M36.32M38.82M25.01M
Total Debt-22.66M51.29M89.92M107.54M124.64M166.16M284.88M
Net Debt--9.94M15.03M-50.56M89.08M88.32M127.35M259.87M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-29.24M-28.29M-24.60M-66.47M-126.02M-76.03M-110.13M-91.24M
Investing Cash Flow-4.60M-3.86M-3.17M-56.06M-7.73M-1.83M14.53M129.00K
Financing Cash Flow33.25M63.62M34.76M223.47M11.38M100.33M98.77M72.81M
Capital Expenditure3.31M1.45M2.93M3.41M2.23M1.83M079.00K
Free Cash Flow-32.54M-29.74M-27.52M--128.25M-77.86M-110.13M-91.24M
Dividends Paid--180.00K-----
FCF to OCF111.32%105.13%111.90%-101.77%102.40%100.00%100.00%
Dividend Paid to FCF---0.65%-----

Earnings

Report DateMay 25, 2021Sep 1, 2021Dec 9, 2021Jan 7, 2022Apr 25, 2022Aug 31, 2022Nov 14, 2022Mar 31, 2023May 10, 2023Aug 7, 2023Nov 8, 2023Mar 28, 2024May 8, 2024Aug 7, 2024Nov 12, 2024Mar 26, 2025May 15, 2025Aug 14, 2025Nov 13, 2025Mar 27, 2026May 14, 2026Aug 10, 2026Nov 12, 2026
EPS Estimate0.00-0.33-0.45-0.24-0.36-0.23-9.00-45.50-0.67-6.50-11.00-0.11-6.37-4.83-1.87-0.115.00-4.30-6.04-9.46-3.50-1.89-7.40
EPS Actual0.12-0.33-0.13-0.05-0.36-0.21-13.50444.11-0.22-4.50-6.00-0.22-8.00-4.50-14.50-0.36-6.28-6.23-9.67-23.020.32-0.63-
Surprise-0.00%71.11%79.17%0.00%8.70%-50.00%1076.07%67.16%30.77%45.45%-100.00%-25.59%6.83%-675.40%-227.27%-225.60%-44.88%-60.10%-143.21%109.14%66.67%-
Timing--After-hours---Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.44B
Enterprise Value302.02M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.96
Price / Book0.62
EPS-33.01
Book Value-23.59
Revenue (TTM)1.50B
Gross Profit (TTM)70.59M
EBITDA-64.48M
Profit Margin-6.55%
Operating Margin10.67%
Return on Equity-192.58%
Return on Assets-13.40%
Shares Outstanding3.91M
Shares Float1.92M
Beta1.62
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 4 analystsTarget 18.00
  • Strong Buy
    2
  • Hold
    2

Ownership Breakdown

Institutions
8.24%
Insiders
48.38%
Retail / Other
43.38%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    70.63K1.81%
  • Geode Capital Management, LLC
    25.90K0.66%
  • CI Private Wealth LLC
    19.74K0.50%
  • Nine Masts Capital Limited
    17.96K0.46%
  • Abundance Wealth Counselors
    16.00K0.41%
  • HRT FINANCIAL LLC
    15.09K0.39%
  • Diversified Trust Co
    13.44K0.34%
  • Susquehanna International Group, LLP
    13.37K0.34%
  • BlackRock Inc
    10.92K0.28%
  • Lido Advisors, LLC
    10.75K0.27%
  • Vanguard Fiduciary Trust Co
    6.48K0.17%
  • UBS Group AG
    1.84K0.05%
  • Vanguard Global Advisers, LLC
    3080.01%
  • BNP Paribas Arbitrage, SA
    360.00%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    28.36K0.72%
  • Fidelity Extended Market Index
    6.66K0.17%
  • Fidelity Total Market Index
    3.21K0.08%
  • Fidelity Series Total Market Index
    2.24K0.06%
  • Fidelity Nasdaq Composite Index
    1.28K0.03%
  • Vanguard U.S. Eq Idx £ Acc
    3080.01%

Stock Splits

  • Apr 14, 20251:50